Total Payments
$6,918
2024 Payments
$1,375
Companies
59
Transactions
219
Medicare Patients
62,162
Medicare Billing
$8.0M
Payment Breakdown by Category
Food & Beverage$6,617 (95.7%)
Education$300.20 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,617 | 213 | 95.7% |
| Education | $300.20 | 6 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $444.84 | 17 | $0 (2024) |
| Celgene Corporation | $379.99 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $371.40 | 8 | $0 (2023) |
| Rigel Pharmaceuticals, Inc. | $360.85 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $353.06 | 15 | $0 (2024) |
| Incyte Corporation | $312.76 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $298.40 | 8 | $0 (2024) |
| Daiichi Sankyo Inc. | $292.66 | 10 | $0 (2024) |
| Medtronic, Inc. | $233.71 | 3 | $0 (2023) |
| Adaptive Biotechnologies Corporation | $195.44 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,375 | 40 | Adaptive Biotechnologies Corporation ($172.71) |
| 2023 | $1,182 | 46 | Celgene Corporation ($209.77) |
| 2022 | $1,325 | 35 | Medtronic, Inc. ($179.62) |
| 2021 | $733.66 | 25 | Rigel Pharmaceuticals, Inc. ($120.85) |
| 2020 | $664.99 | 25 | Daiichi Sankyo Inc. ($126.29) |
| 2019 | $1,487 | 44 | Seattle Genetics, Inc. ($136.41) |
| 2018 | $148.19 | 4 | Incyte Corporation ($99.00) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: HEMATOLOGY | ||||||
| 11/13/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: DESMOID TUMORS | ||||||
| 11/12/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Hematology | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: BioOncology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Hematology | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Oncology | ||||||
| 08/28/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $64.88 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| 07/29/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $125.34 | General |
| 06/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 06/05/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/08/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Oncology | ||||||
| 04/29/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 86 | 18,477 | 203,288 | $13.9M | $2.8M |
| 2022 | 86 | 16,579 | 193,315 | $12.1M | $2.4M |
| 2021 | 84 | 15,155 | 264,166 | $9.1M | $1.6M |
| 2020 | 76 | 11,951 | 195,440 | $6.3M | $1.1M |
Total Patients
62,162
Total Services
856,209
Medicare Billing
$8.0M
Procedure Codes
332
All Medicare Procedures & Services
332 procedure records from CMS Medicare Utilization — Page 1 of 14
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 31 | 21,409 | $2.9M | $917,875 | 31.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 113 | 15,420 | $801,840 | $282,831 | 35.3% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 14 | 6,700 | $804,000 | $238,684 | 29.7% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 104 | 12,500 | $937,500 | $204,387 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 793 | 1,882 | $417,804 | $172,490 | 41.3% |
| J9299 | Injection, nivolumab, 1 mg | Office | 2023 | 11 | 6,841 | $513,000 | $160,901 | 31.4% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 172 | 203 | $1.2M | $146,135 | 11.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 147 | 635 | $287,020 | $59,631 | 20.8% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 80 | 9,640 | $385,600 | $53,197 | 13.8% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 199 | 232 | $253,344 | $45,843 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 404 | 711 | $124,425 | $45,737 | 36.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 161 | 260 | $96,720 | $34,655 | 35.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 182 | 585 | $43,875 | $27,570 | 62.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,139 | 3,061 | $140,806 | $25,515 | 18.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,125 | 3,051 | $277,641 | $23,063 | 8.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 127 | 140 | $560,140 | $22,746 | 4.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 148 | 148 | $73,260 | $22,639 | 30.9% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 28 | 30 | $182,190 | $21,718 | 11.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 1,005 | 2,212 | $320,740 | $17,632 | 5.5% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 37 | 889 | $115,570 | $15,459 | 13.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 1,001 | 2,206 | $121,330 | $12,996 | 10.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 153 | 271 | $91,327 | $12,508 | 13.7% |
| J9041 | Injection, bortezomib, 0.1 mg | Office | 2023 | 11 | 2,765 | $359,450 | $11,745 | 3.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 210 | $29,190 | $11,260 | 38.6% |
| 82310 | Calcium level, total | Office | 2023 | 1,002 | 2,208 | $121,440 | $11,118 | 9.2% |
About Dr. Dejuania Brown-Rawls, D.O
Dr. Dejuania Brown-Rawls, D.O is a Hematology & Oncology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730379132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dejuania Brown-Rawls, D.O has received a total of $6,918 in payments from pharmaceutical and medical device companies, with $1,375 received in 2024. These payments were reported across 219 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($6,617).
As a Medicare-enrolled provider, Brown-Rawls has provided services to 62,162 Medicare beneficiaries, totaling 856,209 services with total Medicare billing of $8.0M. Data is available for 4 years (2020–2023), covering 332 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Myrtle Beach, SC
- Active Since 07/31/2007
- Last Updated 07/30/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1730379132
Products in Payments
- KEYTRUDA (Biological) $410.78
- Pomalyst (Drug) $272.58
- DARZALEX (Biological) $225.51
- Tavalisse (Drug) $220.76
- Enhertu (Drug) $211.74
- clonoSEQ (Device) $195.44
- ADCETRIS (Biological) $188.93
- OSTEOCOOL RF ABLATION SYSTEM (Device) $179.62
- Trodelvy (Drug) $171.30
- OJJAARA (Drug) $145.44
- ZEPZELCA (Drug) $142.14
- Rezlidhia (Drug) $140.09
- MONOFERRIC (Drug) $139.81
- FOUNDATIONONE (Device) $134.87
- OSTEOCOOL RF ABLATION (Device) $123.50
- VERZENIO (Drug) $120.14
- Monarch Platform (Device) $117.89
- THERASPHERE-BIO (Device) $114.24
- IMBRUVICA (Drug) $106.69
- FARYDAK (Drug) $106.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Myrtle Beach
Dr. Emily Touloukian, D.o, D.O
Hematology & Oncology — Payments: $21,558
Hematology & Oncology $21,558
Nicolina Scibelli
Hematology & Oncology — Payments: $4,838
Hematology & Oncology $4,838
Faria Ali, Md, MD
Hematology & Oncology — Payments: $1,550
Hematology & Oncology $1,550
Rebecca Cody, Md, MD
Hematology & Oncology — Payments: $1,356
Hematology & Oncology $1,356
Vijay Paudel, Md, MD
Hematology & Oncology — Payments: $1,134
Hematology & Oncology $1,134
Renwick Goldberg, Md, MD
Hematology & Oncology — Payments: $973.09
Hematology & Oncology $973.09